Stacey Main

Geisinger Medical Center · company speakers →

healthcare-servicespharma-biotech

Is this you? Claim this profile →

No public contact links on file.

Speaking history

International Conference on Neurology and Neurological Disorders

22 June 2026 Barcelona, Spain “In patients with multiple sclerosis, does the transition from brand name tecfidera to generic dimethyl fumerate result in statistically significant shifts in laboratory surveillance data, MRI imaging, patient-reported side effects, and compliance?”

Topics this speaker covers

healthcare-servicespharma-biotech

Sectors

healthcare_medtech_pharma

Sourcing speakers for your event?

Browse the speaker directory →